Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated analogs of bioactive molecules. Its structure supports the creation of compounds with enhanced metabolic stability and receptor binding affinity. Commonly employed in the preparation of selective enzyme inhibitors and central nervous system agents. Also utilized in research settings for the design of novel fluorinated aromatic amines with potential therapeutic activity.